LIBERTY Endovascular Robotic System

Microbot Medical is a commercial-stage medical device company specializing in the development of transformational micro-robotic technologies for endovascular and endoluminal procedures. The company's flagship product is the LIBERTY Endovascular Robotic System, the world's first FDA-cleared, single-use, remotely operated robotic system designed for peripheral endovascular procedures. LIBERTY aims to improve procedural precision, safety, and efficiency while reducing radiation exposure and physical strain for interventional physicians. Additionally, Microbot Medical is developing other micro-robotic platforms, including the Self-Cleaning Shunt (SCS) for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH).